Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery

被引：0
|
作者：
Lauren G Friedman
Katherine Price
Rachel F Lane
Aaron J Carman
Penny A Dacks
Diana W Shineman
Howard M Fillit
机构：
[1] Columbia University,
[2] Taub Institute,undefined
[3] Icahn School of Medicine at Mount Sinai,undefined
[4] Alzheimer’s Drug Discovery Foundation,undefined
来源：
Alzheimer's Research & Therapy | / 6卷
关键词：
Mild Cognitive Impairment; Liraglutide; Atomoxetine; Cholesteryl Ester Transfer Protein; Cerebral Amyloid Angiopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Alzheimer’s Drug Discovery Foundation’s 14th International Conference on Alzheimer’s Drug Discovery was held on 9 and 10 September in Jersey City, NJ, USA. This annual meeting highlights novel therapeutic approaches supported by the Alzheimer’s Drug Discovery Foundation in development for Alzheimer’s disease and related dementias.
引用
收藏
相关论文
共 50 条
  • [31] The challenges of drug discovery and drug development for cognitive aging and Alzheimer's disease
    Fillit, H
    O'Connell, A
    DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000, 2002, : 1 - 4
  • [32] The current landscape in Alzheimer's disease research and drug discovery
    Devenish, Sean R. A.
    DRUG DISCOVERY TODAY, 2020, 25 (06) : 943 - 945
  • [33] An alternative approach to drug discovery for Alzheimer's disease dementia
    Schubert, David
    Maher, Pamela
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (13) : 1681 - 1688
  • [34] Advanced analytical methodologies in Alzheimer's disease drug discovery
    De Simone, Angela
    Naldi, Marina
    Tedesco, Daniele
    Bartolini, Manuela
    Davani, Lara
    Andrisano, Vincenza
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 178
  • [35] Animal models in the drug discovery pipeline for Alzheimer's disease
    Van Dam, Debby
    De Deyn, Peter Paul
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) : 1285 - 1300
  • [36] Strategies for drug discovery for cognitive aging and alzheimer’s disease
    Howard M. Fillit
    Alan W. O’Connell
    Lorenzo M. Refolo
    Journal of Molecular Neuroscience, 2002, 19 : 1 - 3
  • [37] A Comprehensive Computational Perspective in Drug Discovery for Alzheimer's Disease
    Selvaraj, Manikandan
    Sadasivam, Karthik
    Jothimani, Muralidharan
    Muthusamy, Karthikeyan
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (12) : 2113 - 2123
  • [38] Worming Our Way to Alzheimer's Disease Drug Discovery
    Iyer, Sangeetha
    Pierce-Shimomura, Jonathan T.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (05) : 396 - 398
  • [39] Alzheimer's Society takes on drug-discovery challenge
    不详
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (08) : 906 - 906
  • [40] Phytochemicals for Drug Discovery in Alzheimer's Disease: In Silico Advances
    Sharma, Smriti
    Bhatia, Vinayak
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (25) : 2848 - 2860
12345